VALSARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN ORAL

Compare VALSARTAN AND HYDROCHLOROTHIAZIDE (Valsartan and Hydrochlorothiazide) and VALSARTAN ORAL (Valsartan) — clinical data, side effects, and patient experiences.

VALSARTAN AND HYDROCHLOROTHIAZIDE

Valsartan and Hydrochlorothiazide · ARB

How it works

12.1 Mechanism of Action Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pr...

Approved for

1 INDICATIONS AND USAGE Valsartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes

including

OralTablet

VALSARTAN ORAL

Valsartan · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Valsartan is an angiotensin II receptor blocker (ARB) indicated for: Hypertension in adults and children six years and older

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions ( 1.1 ) Heart failure (NYHA class II-IV)

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

OralTablet

Quick Comparison

VALSARTAN AND HYDROCHLOROTHIAZIDEVALSARTAN ORAL

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

VALSARTAN AND HYDROCHLOROTHIAZIDE

Fatigue

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Low Blood Pressure

1-10%

Cough

1-10%

Drug Not Working

1-10%

General Unwellness

1-10%

Weight Loss

1-10%

VALSARTAN ORAL

Fatigue

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Low Blood Pressure

1-10%

Cough

1-10%

Drug Not Working

1-10%

General Unwellness

1-10%

Weight Loss

1-10%

FDA Warnings

VALSARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume depletion prior to initiation
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on valsartan and hydrochlorothiazide

VALSARTAN ORAL

5 WARNINGS AND PRECAUTIONS Observe for signs and symptoms of hypotension ( 5
1 Fetal Toxicity Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
Peak plasma concentrations of valsartan are higher following administration of valsartan oral solution and may result in increased risk of hypotension as compared to administration of valsartan tablets [see Clinical Pharmacology (12

Clinical Trial Data

No head-to-head clinical studies found for VALSARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN ORAL.

VALSARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN ORAL: What You Should Know

Key Differences

Both VALSARTAN AND HYDROCHLOROTHIAZIDE and VALSARTAN ORAL belong to the ARB class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Shared Indications

Both medications are approved for to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, including, as appropriate. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.

Safety Considerations

VALSARTAN AND HYDROCHLOROTHIAZIDE carries 4 FDA warnings. VALSARTAN ORAL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

SACUBITRIL AND VALSARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→VALSARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→IRBESARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→TELMISARTAN vs VALSARTAN AND HYDROCHLOROTHIAZIDE→TELMISARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN AND HYDROCHLOROTHIAZIDE→IRBESARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN AND HYDROCHLOROTHIAZIDE→

Loading comparison data...

VALSARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN ORAL

Compare VALSARTAN AND HYDROCHLOROTHIAZIDE (Valsartan and Hydrochlorothiazide) and VALSARTAN ORAL (Valsartan) — clinical data, side effects, and patient experiences.

VALSARTAN AND HYDROCHLOROTHIAZIDE

Valsartan and Hydrochlorothiazide · ARB

How it works

12.1 Mechanism of Action Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II). Angiotensin II is the principal pr...

Approved for

1 INDICATIONS AND USAGE Valsartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes

including

OralTablet

VALSARTAN ORAL

Valsartan · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Valsartan is an angiotensin II receptor blocker (ARB) indicated for: Hypertension in adults and children six years and older

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions ( 1.1 ) Heart failure (NYHA class II-IV)

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

OralTablet

Quick Comparison

VALSARTAN AND HYDROCHLOROTHIAZIDEVALSARTAN ORAL

Drug Class

ARB

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

VALSARTAN AND HYDROCHLOROTHIAZIDE

Fatigue

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Low Blood Pressure

1-10%

Cough

1-10%

Drug Not Working

1-10%

General Unwellness

1-10%

Weight Loss

1-10%

VALSARTAN ORAL

Fatigue

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Low Blood Pressure

1-10%

Cough

1-10%

Drug Not Working

1-10%

General Unwellness

1-10%

Weight Loss

1-10%

FDA Warnings

VALSARTAN AND HYDROCHLOROTHIAZIDE

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume depletion prior to initiation
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on valsartan and hydrochlorothiazide

VALSARTAN ORAL

5 WARNINGS AND PRECAUTIONS Observe for signs and symptoms of hypotension ( 5
1 Fetal Toxicity Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
Peak plasma concentrations of valsartan are higher following administration of valsartan oral solution and may result in increased risk of hypotension as compared to administration of valsartan tablets [see Clinical Pharmacology (12

Clinical Trial Data

No head-to-head clinical studies found for VALSARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN ORAL.

VALSARTAN AND HYDROCHLOROTHIAZIDE vs VALSARTAN ORAL: What You Should Know

Key Differences

Shared Indications

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.